Survival outcome of sandwich therapy with induction chemoimmunotherapy followed by concurrent chemoradiotherapy and sequential immune maintenance therapy in locally advanced unresectable esophageal squamous cell carcinoma (ESCC) patients: A multi-center prospective study.